Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Qulipta (Atogepant) is a prescription oral medication manufactured by AbbVie used for the preventive treatment of episodic and chronic migraine in adults. It belongs to a class of drugs called CGRP receptor antagonists (gepants). Unlike injectable migraine preventives, Qulipta is taken as a once-daily tablet, making it a convenient option for patients who prefer oral medications. It was FDA-approved in September 2021 for episodic migraine and later expanded to include chronic migraine prevention.
Qulipta works by blocking calcitonin gene-related peptide (CGRP) receptors in the brain. CGRP is a neuropeptide that plays a central role in triggering migraine attacks — it promotes vasodilation, neurogenic inflammation, and pain signal transmission in the trigeminal system. By antagonizing CGRP receptors, Qulipta helps prevent the cascade of events that leads to migraine, reducing the frequency and severity of attacks over time.
Qulipta scores a 55 out of 100 on our findability scale, meaning it can be moderately difficult to locate. While Qulipta is not on the FDA Drug Shortage list, it is a brand-name-only specialty medication with no generic alternative available. Many pharmacies don't routinely stock it, and patients often need to call multiple locations or use specialty pharmacies. Insurance prior authorization delays can further complicate access. Using Medfinder can help you quickly locate pharmacies that have Qulipta in stock near you.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.
Qulipta can be prescribed by several types of healthcare providers, including:
Telehealth providers can also prescribe Qulipta, making it accessible even if you don't have a local specialist.
No. Qulipta is not a controlled substance and has no DEA scheduling. It does not carry a risk of abuse or dependence. No special prescribing restrictions apply — it can be prescribed with a standard prescription and refilled normally.
Most side effects are mild and tend to improve over the first few weeks of treatment. Serious but rare side effects include hypersensitivity reactions, elevated blood pressure, and liver enzyme elevations. Contact your doctor if you experience swelling of the face, lips, or throat, or any signs of an allergic reaction.
If you're unable to find or afford Qulipta, several alternatives are available for migraine prevention:
Qulipta is metabolized by the CYP3A4 enzyme system, so interactions can occur with medications that affect this pathway:
Always inform your doctor about all medications, supplements, and herbal products you are taking before starting Qulipta.
Qulipta is a valuable oral option for migraine prevention, offering a convenient once-daily tablet as an alternative to injectable CGRP therapies. While its brand-name-only status and high retail price can make access challenging, manufacturer savings programs and insurance coverage can significantly reduce out-of-pocket costs. If you're having trouble finding Qulipta at your local pharmacy, try using Medfinder to check real-time availability near you.
%2C%20Color%3DOriginal.png)
